Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Avista Therapeutics Partners with Forge Biologics for AAV Development and cGMP Manufacturing
Thursday, August 14, 2025Avista Therapeutics has entered a strategic partnership with Forge Biologics The collaboration will focus on advancing AVST Avistas lead gene therapy candidate for Xlinked retinoschisis XLRS a serious inherited retinal disorder
BioCardia Enters into Partnership with CART-Tech for Heart3D™ Fusion Imaging in Cardiology
Thursday, August 14, 2025BioCardia has entered into an exclusive agreement with CARTTechThe collaboration aims to develop and commercialise the HeartD Fusion Imaging system for interventional cardiology
Apertura Gene Therapy Licences Blood-Brain Barrier-Penetrant AAV Capsid for CNS Treatments
Thursday, August 14, 2025Apertura Gene Therapy has signed multiple licensing agreements to advance the use of its bloodbrain barrierpenetrant adenoassociated virus AAV capsid technology in treatments for central nervous system CNS disorders
Bayer Enters into Collaboration with Kumquat Biosciences for Precision Oncology
Wednesday, August 13, 2025Bayer has entered into an exclusive global licence and collaboration agreement with Kumquat Biosciences to develop and commercialise Kumquats KRAS GD inhibitor
PureTech Launches Celea Therapeutics to Advance New Treatments for Respiratory Diseases
Wednesday, August 13, 2025PureTech Health has announced the creation of Celea Therapeutics a new business focused on developing treatments for serious respiratory conditions
Airway Therapeutics Receives Approval for Zelpultide Alfa Study in Preterm Infants
Wednesday, August 13, 2025Airway Therapeutics has received approval from the European Medicines Agencys Paediatric Committee PDCO for its Paediatric Investigation Plan PIP for zelpultide alfa
Viatris Receives FDA Approval for First Generic Iron Sucrose Injection in the U.S.
Tuesday, August 12, 2025Viatris has gained approval from the US Food and Drug Administration FDA for its Iron Sucrose Injection USP marking the first generic version of Venofer Injection available in the country
Kexing Biopharm Enters into Partnership with IQVIA to Boost Global Market Reach
Tuesday, August 12, 2025Kexing Biopharm has entered into a strategic partnership with IQVIAThe collaboration aims to speed up the global clinical development regulatory approval and commercialisation of Kexings innovative medicines and biosimilars
Ono Enters into Agreement with Seikagaku for Joint Development and Marketing of Gel-One
Friday, August 08, 2025Ono Pharmaceutical and Seikagaku have finalised an agreement to jointly develop and market GelOne a treatment for osteoarthritis in Japan
Astria Therapeutics Enters into Agreement with Kaken Pharmaceutical to Develop and Commercialise Navenibart for HAE Treatment
Thursday, August 07, 2025Astria Therapeutics has entered into an exclusive licensing agreement with Kaken Pharmaceutical to develop and commercialise navenibart for hereditary angioedema HAE in Japan
